THE 3CLpro INHIBITOR ALG-097111 POTENTLY INHIBITS SARS-CoV-2 REPLICATION IN HAMSTERS
There is an urgent need for potent drugs for the treatment or prevention of SARS-CoV-2 infections. Inhibition of viral proteases has been proven a successful therapeutic strategy for infections with HIV and HCV. Most reported inhibitors of the SARS-CoV-2 3-chymotrypsin-like (3CL) cysteine protease also target cathepsin L; the latter is involved in the SARS-CoV-2 entry…